Advertisement
Screener

GUARDANT HEALTH, INC. (GH) EBITDA

GUARDANT HEALTH, INC. (GH) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$119.56M*; Operating income -$129.12M; Depreciation and amortization $9.56M*.
  • 2026-03-31: Basis Reported; EBITDA -$111.91M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$110.76M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$89.58M*; Operating income -$98.99M; Depreciation and amortization $9.41M*.

Complete source-backed ebitda history.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$119.56M*-$129.12M$9.56M*$334.98M-35.69%*$11.76M*-$57.78M*$115.95M$96.53M(m)$185.00K
2026-03-31Reported-$111.91M(m)(m)(m)-37.10%$5.58M-$65.62M$104.92M$91.04M(m)$372.00K
2025-12-31Reported-$110.76M(m)(m)(m)-39.38%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$89.58M*-$98.99M$9.41M*$265.20M-33.78%*$10.35M*-$35.41M*$93.59M$89.96M(m)$136.00K
2025-06-30Reported-$96.37M*-$106.41M$10.04M*$232.09M-41.52%*$5.65M*-$60.28M*$81.20M$87.45M(m)$38.00K
2025-03-31Reported-$100.81M(m)(m)(m)-49.54%$4.46M-$62.69M$74.72M$88.52M(m)$290.00K
2024-12-31Reported-$115.51M(m)(m)(m)-57.24%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$106.73M*-$117.33M$10.60M*$191.48M-55.74%*$4.20M*-$51.06M*$74.49M$87.31M(m)$30.00K
2024-06-30Reported-$90.00M*-$100.62M$10.62M*$177.24M-50.78%*$5.08M*-$94.00M*$72.42M$83.10M(m)$133.00K
2024-03-31Reported-$88.97M(m)(m)(m)-52.80%$6.93M-$30.28M$65.30M$83.80M(m)$405.00K
2023-12-31Reported-$186.64M(m)(m)(m)-120.37%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$102.51M*-$113.54M$11.04M*(m)(m)$2.37M*-$77.79M*(m)$93.85M(m)$490.00K
2023-06-30Reported-$108.98M*-$119.62M$10.63M*(m)(m)$6.51M*-$94.02M*(m)$90.36M(m)$496.00K
2023-03-31Reported-$123.71M(m)(m)(m)-96.11%$7.52M-$74.44M(m)$93.13M(m)$240.00K
2022-12-31Reported-$135.95M(m)(m)(m)-107.14%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$134.79M*-$144.60M$9.81M*(m)(m)$21.73M*-$78.16M*(m)$100.02M(m)$115.00K
2022-06-30Reported-$121.54M*-$130.32M$8.79M*(m)(m)$23.03M*-$111.94M*(m)$85.45M(m)$446.00K
2022-03-31Reported-$116.14M(m)(m)(m)-120.85%$22.70M-$28.62M(m)$81.76M(m)-$24.00K
2021-12-31Reported-$92.12M(m)(m)(m)-85.21%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$101.74M*-$107.29M$5.54M*(m)(m)$22.15M*-$53.15M*(m)$70.97M(m)$96.00K
2021-06-30Reported-$92.02M*-$97.64M$5.63M*(m)(m)$18.68M*-$62.59M*(m)$63.72M(m)$83.00K
2021-03-31Reported-$102.85M(m)(m)(m)-130.75%$9.59M-$16.29M(m)$55.51M(m)$110.00K
2020-12-31Reported-$86.56M(m)(m)(m)-110.53%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$69.90M*-$74.25M$4.35M*(m)(m)$9.79M*-$8.06M*(m)$36.24M(m)$68.00K
2020-06-30Reported-$50.81M*-$54.62M$3.81M*(m)(m)$9.51M*-$23.36M*(m)$36.32M(m)$34.00K
2020-03-31Reported-$31.61M(m)(m)(m)-46.82%$9.60M-$13.28M(m)$37.02M(m)$14.00K
2019-12-31Reported-$22.51M(m)(m)(m)-35.80%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$14.53M*-$17.48M$2.95M*(m)(m)$5.88M*$1.35M*(m)$24.57M(m)-$202.00K
2019-06-30Reported-$12.61M*-$15.27M$2.66M*(m)(m)$3.05M*-$13.84M*(m)$19.53M(m)-$1.21M
2019-03-31Reported-$21.31M(m)(m)(m)-58.14%$2.71M-$4.30M(m)$16.32M(m)$26.00K
2018-12-31Reported-$25.22M(m)(m)(m)-76.71%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$22.20M*-$24.20M$2.00M*(m)(m)$5.91M*-$22.05M*(m)$14.25M(m)$0.00
2018-06-30Reported-$21.13M*-$22.70M$1.57M*(m)(m)$7.34M*-$17.04M*(m)$11.55M(m)$3.00K
2018-03-31Reported-$17.25M(m)(m)(m)-103.35%$4.02M-$6.56M(m)$8.26M(m)$0.00
2017-12-31Reported-$14.23M(m)(m)(m)-71.12%(m)(m)(m)(m)(m)(m)
2017-09-30Reported(m)-$28.68M(m)(m)(m)(m)(m)(m)$7.25M(m)$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$397.51M(m)(m)(m)-40.48%$48.31M-$184.76M$349.01M$364.19M(m)-$1.26M
2024-12-31Reported-$401.21M(m)(m)(m)-54.29%$35.09M-$239.86M$289.80M$347.75M(m)$1.28M
2023-12-31Reported-$521.84M(m)(m)(m)-92.53%$20.49M-$324.98M$227.05M$367.19M(m)$685.00K
2022-12-31Reported-$508.42M(m)(m)(m)-113.10%$77.46M-$309.46M(m)$373.81M(m)$1.14M
2021-12-31Reported-$388.73M(m)(m)(m)-104.04%$75.03M-$209.02M(m)$263.22M(m)$300.00K
2020-12-31Reported-$238.89M(m)(m)(m)-83.31%$36.17M-$103.93M(m)$149.86M(m)$379.00K
2019-12-31Reported-$70.96M(m)(m)(m)-33.10%$18.72M-$47.13M(m)$86.29M(m)-$1.87M
2018-12-31Reported-$85.81M(m)(m)(m)-94.67%$20.20M-$72.19M(m)$50.71M(m)$38.00K
2017-12-31Reported-$71.41M(m)(m)(m)-143.26%$6.68M-$72.23M(m)$25.56M(m)$7.00K
2016-12-31Reported-$40.15M(m)(m)(m)-159.03%$1.77M-$36.71M(m)$10.86M(m)$6.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30